AbbVie and Johnson & Johnson’s Imbruvica is in fifth place with sales expected to reach $11.9 billion by 2025. The drug has received FDA approval for multiple oncology indications and chronic ...
It has been announced that global management consulting and technology firm ZS Associates has reached a definitive agreement to acquire Trials.ai, an intelligent study design company that uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback